| |
| |
|
| Insider
Information: |
Lawrence David |
| Relationship: |
Chief, Bus. Ops & PAO |
| City: |
Hawthorne |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
13,811 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$6,933 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
13,811 |
|
|
| Total
Value |
$6,933 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Acorda Therapeutics Inc |
ACOR |
Chief, Bus. Ops & PAO |
2020-12-01 |
13,811 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
92 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ACOR |
Acorda Therapeutics Inc |
Chief of Business Operations |
• – – |
2015-12-01 |
4 |
AS |
$38.08 |
$272,954 |
D/D |
(7,167) |
9,202 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief of Business Operations |
• – – |
2015-12-18 |
4 |
AS |
$40.62 |
$1,585,488 |
D/D |
(39,026) |
9,202 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief of Business Operations |
• – – |
2016-06-22 |
4 |
AS |
$25.09 |
$12,545 |
D/D |
(500) |
9,202 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief of Business Operations |
• – – |
2016-06-22 |
4 |
OE |
$8.50 |
$4,250 |
D/D |
500 |
9,702 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief, Bus. Ops & PAO |
• – – |
2018-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
5,197 |
9,890 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Financial Officer |
• – – |
2007-09-26 |
4 |
AS |
$18.56 |
$37,703 |
D/D |
(2,008) |
10,037 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Financial Officer |
• – – |
2009-12-01 |
4 |
AS |
$24.51 |
$182,964 |
D/D |
(7,466) |
10,800 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Financial Officer |
• – – |
2009-12-16 |
4 |
AS |
$24.48 |
$122,420 |
D/D |
(5,000) |
10,800 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Financial Officer |
• – – |
2010-01-22 |
4 |
AS |
$28.00 |
$140,000 |
D/D |
(5,000) |
10,800 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Financial Officer |
• – – |
2010-02-02 |
4 |
AS |
$30.00 |
$150,000 |
D/D |
(5,000) |
10,800 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Financial Officer |
• – – |
2010-03-10 |
4 |
S |
$34.16 |
$409,961 |
D/D |
(12,000) |
10,800 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief of Business Operations |
• – – |
2014-12-01 |
4 |
AS |
$35.60 |
$316,763 |
D/D |
(8,898) |
11,046 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief of Business Operations |
• – – |
2014-12-18 |
4 |
AS |
$40.11 |
$1,087,399 |
D/D |
(27,109) |
11,046 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Financial Officer |
• – – |
2007-09-12 |
4 |
AS |
$15.91 |
$32,087 |
D/D |
(2,007) |
12,045 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Financial Officer |
• – – |
2007-12-27 |
4 |
OE |
$2.60 |
$18,200 |
D/D |
7,000 |
12,123 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Financial Officer |
• – – |
2008-01-11 |
4 |
OE |
$2.60 |
$18,200 |
D/D |
7,000 |
12,123 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Financial Officer |
• – – |
2008-06-04 |
4 |
S |
$29.76 |
$357,873 |
D/D |
(12,000) |
12,400 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Financial Officer |
• – – |
2008-06-12 |
4 |
S |
$21.67 |
$218,622 |
D/D |
(7,000) |
12,400 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief, Bus. Ops & PAO |
• – – |
2019-12-02 |
4 |
AS |
$1.60 |
$1,880 |
D/D |
(1,176) |
12,961 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief, Bus. Ops & PAO |
• – – |
2018-06-08 |
4 |
OE |
$20.59 |
$105,421 |
D/D |
5,120 |
13,244 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Financial Officer |
• – – |
2010-12-01 |
4 |
AS |
$26.39 |
$289,393 |
D/D |
(10,905) |
13,645 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief, Bus. Ops & PAO |
• – – |
2020-12-01 |
4 |
D |
$0.65 |
$738 |
D/D |
(1,141) |
13,811 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Financial Officer |
• – – |
2007-06-15 |
4 |
S |
$18.48 |
$37,087 |
D/D |
(2,007) |
14,052 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief, Bus. Ops & PAO |
• – – |
2019-03-08 |
4 |
A |
$0.00 |
$0 |
D/D |
9,045 |
14,137 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief of Business Operations |
• – – |
2013-12-02 |
4 |
AS |
$33.51 |
$363,141 |
D/D |
(10,836) |
14,194 |
0 |
- |
|
92 Records found
|
|
Page 2 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
